Literature DB >> 19131263

Impact of prior antibiotic use in culture-negative endocarditis: review of 86 cases from southern Pakistan.

Bilal Karim Siddiqui1, Muhammad Tariq, Atif Jadoon, Mahboob Alam, Ghulam Murtaza, Bilal Abid, Muhammad Jawad Sethi, Mehnaz Atiq, Sohail Abrar, Raymond A Smego.   

Abstract

BACKGROUND: A large number of patients treated at our hospital for endocarditis have negative cultures. Taking into consideration the fact that many of these patients receive antibiotics prior to referral, we decided to study culture-negative endocarditis in Pakistan.
METHODS: The medical records of all patients admitted to the Aga Khan University Hospital, Pakistan, for the period from 1988 to 2001, with an underlying diagnosis of infective endocarditis (IE) and negative cultures, were reviewed.
RESULTS: Of the 159 patients diagnosed with IE by revised Duke criteria, 86 (54.1%) had persistent negative cultures. More than half of these patients (52%) had received antibiotics before being referred to our center. Patients with culture-negative endocarditis were less likely to be classified as definite endocarditis by revised Duke criteria (p<0.001, 95% CI 0.07-0.3) or to have large vegetations (p=0.021, 95% CI 0.05-0.5), and more likely to have a mitral valve prolapse (p=0.003, 95% CI 1.6-2.3). Definite endocarditis (p=0.042, 95% CI 1.02-7.4), heart failure (p=0.008, 95% CI 1.4-12.7), renal failure (p=0.017, 95% CI 1.16-40.7), embolism (p=0.019, 95% CI 1.2-38.8), and neurological complications (p=0.02, 95% CI 1.16-9.2) were associated with an increased mortality.
CONCLUSION: Culture-negative endocarditis is very common among patients with IE in Pakistan. The presentation, laboratory findings, and complications are similar to those for culture-positive endocarditis. It is postulated that previous antibiotic treatment is the most common cause of culture-negative endocarditis in our hospital.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131263     DOI: 10.1016/j.ijid.2007.10.009

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  Factors Affecting Mortality in Patients with Blood-Culture Negative Infective Endocarditis.

Authors:  Lira Firiana; Bambang Budi Siswanto; Emir Yonas; Radityo Prakoso; Raymond Pranata
Journal:  Int J Angiol       Date:  2020-02-04

Review 2.  Salvage microbiology: opportunities and challenges in the detection of bacterial pathogens following initiation of antimicrobial treatment.

Authors:  John J Farrell; Andrea M Hujer; Rangarajan Sampath; Robert A Bonomo
Journal:  Expert Rev Mol Diagn       Date:  2014-12-19       Impact factor: 5.225

3.  Infective endocarditis in Ethiopian children: a hospital based review of cases in Addis Ababa.

Authors:  Tamirat Moges; Etsegenet Gedlu; Petros Isaakidis; Ajay Kumar; Rafael Van Den Berge; Mohammed Khogali; Amha Mekasha; Sven Gudmund Hinderaker
Journal:  Pan Afr Med J       Date:  2015-01-28

4.  Clinicomicrobiological spectrum of infective endocarditis - from a tertiary care centre in south India.

Authors:  Kanne Padmaja; Sukanya Sudhaharan; Lakshmi Vemu; Oruganti Sai Satish; Padmasri Chavali; Mamidi Neeraja
Journal:  Iran J Microbiol       Date:  2017-10

5.  Antibiotic prescribing practices in paediatric septic shock in a tertiary care hospital in a resource limited setting: an audit.

Authors:  Varsha Vekaria-Hirani; Rashmi Kumar; Rachel Musoke
Journal:  Pan Afr Med J       Date:  2019-11-07

6.  Antibiotics and Missed Etiological Diagnosis of Infective Endocarditis: A Dangerous Duo.

Authors:  Daniele Roberto Giacobbe; Antonio Salsano; Francesco Santini; Matteo Bassetti
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964

7.  Early surgical intervention in culture-negative endocarditis of the aortic valve complicated by abscess in an infant: A case report.

Authors:  Yan-Feng Yang; Fei-Fei Si; Ting-Ting Chen; Ling-Xia Fan; Ya-Heng Lu; Mei Jin
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.